CTRI Number |
CTRI/2020/07/026593 [Registered on: 15/07/2020] Trial Registered Prospectively |
Last Modified On: |
28/02/2024 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Ayurveda Diagnostic |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
Management of Chemotherapy associated Anemia through Nagaphani fruit |
Scientific Title of Study
|
Pharmaco-therapeutic evaluation of Nagaphani( Opuntia elatior Mill.) fruit in Pandu with special reference to its efficacy in Cancer and Chemotherapy associated Anemia |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Sharada Ramesh |
Designation |
Ph D scholar |
Affiliation |
Institute of Post Graduate Teaching and Research in Ayurveda |
Address |
Jamnagar Department of Dravyaguna 3rd floor IPGT and RA GAU Jamnagar Jamnagar GUJARAT 361008 India |
Phone |
9620554829 |
Fax |
|
Email |
dr.shaaradaramesh@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Prof Rabinarayan Acharya |
Designation |
Professor and HOD |
Affiliation |
Institute of Post Graduate Teaching and Research in Ayurveda |
Address |
Room no 329 Institute of Post Graduate Teaching and Research in Ayurveda GAU Jamnagar Department of Dravyaguna 3rd floor IPGT and RA GAU Jamnagar Jamnagar GUJARAT 361008 India |
Phone |
9924585855 |
Fax |
|
Email |
drrnacharya@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Prof Rabinarayan Acharya |
Designation |
Professor and HOD |
Affiliation |
Institute of Post Graduate Teaching and Research in Ayurveda |
Address |
Room no 329 Institute of Post Graduate Teaching and Research in Ayurveda GAU Jamnagar Department of Dravyaguna 3rd floor IPGT and RA GAU Jamnagar Jamnagar GUJARAT 361008 India |
Phone |
9924585855 |
Fax |
|
Email |
drrnacharya@gmail.com |
|
Source of Monetary or Material Support
|
Institute of Post Graduate Teaching and Research in Ayurveda GAU Jamnagar |
|
Primary Sponsor
|
Name |
Institute for Post Graduate Teaching and Research in Ayurveda |
Address |
Institute of Post Graduate Teaching and Research in Ayurveda GAU Jamnagar |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Sharada Ramesh |
PG Ayurveda Hospital |
OPD no 10 Institute of Post Graduate Teaching and Research in Ayurveda GAU Jamnagar Jamnagar GUJARAT |
9620554829
dr.shaaradaramesh@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: D648||Other specified anemias, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
In Group A Nagaphani Phala Swarasa( fruit juice) |
In Group A Nagaphani Phala Swarasa( fruit juice) 40ml/day in two divided before meal for the duration of 60 days will be given orally |
Comparator Agent |
In Group B conventional treatment of Chemotherapy associated Anemia |
In Group B conventional treatment of Chemotherapy associated Anemia will be given for 60 days |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
70.00 Year(s) |
Gender |
Both |
Details |
Any type of Cancer patients under Chemotherapy associated with Anemia
Hb% below 12gm for female and below 13gm for male or reduced RBC count
|
|
ExclusionCriteria |
Details |
Patient who are not under Chemotherapy
Pregnancy and Lactation
Severe Renal/Hepatic/Cardiac disease
Any continuing blood loss
Hemoglobin percentage below 6gm |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Increase in Hb percentage |
60 days |
|
Secondary Outcome
|
Outcome |
TimePoints |
Increased RBC count |
60 days |
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "25"
Final Enrollment numbers achieved (India)="25" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
16/08/2020 |
Date of Study Completion (India) |
22/01/2022 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
none yet |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
An open labeled randomized controlled clinical trial will be carried out to assess the efficacy of Nagaphani (Opuntia elatior Mill.) fruit juice in chemotherapy associated Anemia on a minimum of 30 patients in the dose of 40 ml per day orally before meal in two divided doses for a duration of 60 days and followup of 30 days will be carried out along with conventional treatment protocol and compared with conventional group |